Sign Up to like & get
recommendations!
3
Published in 2023 at "Journal for Immunotherapy of Cancer"
DOI: 10.1136/jitc-2022-005925
Abstract: Background Although immune checkpoint blockade (ICB) and adoptive T cell transfer (ACT) therapy have achieved impressive clinical outcomes, majority of patients do not respond to immunotherapy. Tumor-infiltrating T cells, a critical factor to immunotherapy, is…
read more here.
Keywords:
tumor infiltrating;
immunotherapy;
tumor;
99mtc sum ... See more keywords